Bio Innovation

Accelerators

• Terp Startup Accelerator is a summer program that helps student entrepreneurs make progress on their startups for eight weeks over the summer. By the end of the accelerator, students should have: made substantial progress on their product or service; secured or increased initial customers and partners; have the ability to make the "go/no-go" decision based on metrics and market indicators.

Incubators

• Mtech Ventures is a UMD incubator for technology-based innovations commercialized at the university. This incubator helps early-stage startups survive the critical period in their development between conducting customer discovery and raising their first round of venture capital. The facility offers affordable space and hands-on mentoring for early stage companies.

Centers

• BioWorkshop offers access to an array of cutting-edge scientific instruments spanning from Biological Imaging, Cellular and Biochemical Analysis to Biomaterial Characterization, and Histology.
• Center for Engineering Complex Tissues - The fabrication of complex engineered tissues remains a grand challenge in regenerative medicine. These complex tissues – bone, cartilage, vasculature, and cardiac – are characterized by dense cellularity, patterned cellular composition, and controlled matrix presentation. Mimicking this native complexity within in vitro cell-based constructs and biomaterial formulations has enormous potential for clinical applications towards repair and regeneration of tissues. The objective of CECT is to address this clinical opportunity by applying three-dimensional (3D) printing strategies to produce novel tissue engineered constructs with transplantation capabilities.
• Center of Excellence in Regulatory Science and Innovation (M-CERSI) - This center focuses on modernizing and improving the ways drugs and medical devices are reviewed and evaluated. This center is a collaborative partnership between the University of Maryland, College Park, and the University of Maryland, Baltimore.
• NanoCenter promotes major nano research and education initiatives, provides one-stop shopping for those seeking expertise and/or partnerships at Maryland, and supplies infrastructure to facilitate nano activities at Maryland through equipment, staff support, and informational and administrative functions.
• Rehabilitation Engineering Research Center (RERC RAH2) - This center focuses on improving rehabilitation interventions for patients with sensorimotor impairments resulting from a stroke, as well as for older adults who face a high risk of falls. The center aims to conduct advanced assessment and impairment-specific rehabilitation in combined home and hospital settings to benefit people with disability.

Institutes

• Robert E. Fischell Institute for Biomedical Devices - Brings together skilled scientists, medical doctors, health practitioners, and bioengineers who are working to research, design, and build biomedical devices to benefit humanity, while simultaneously training the next generation of innovators.

Facilities

• A. James Clark Hall boasts more than 100,000 square feet of instructional and research space with three floors dedicated to the Fischell Department of Bioengineering and the Robert E. Fischell Institute for Biomedical Devices. To help spur an organic flow of ideas, Clark Hall houses an Innovation Lab, in which students from all eight engineering departments work collaboratively on cross-disciplinary research and design work. State-of-the-art optical laser and imaging laboratories feature advanced technology in digital fabrication, rapid prototyping, 3-D printing, optics, and bioinformatics. In the imaging suite, students and faculty have the ability to examine molecular resolution of pathogens that show how a nano-carrier delivers a drug to a specific tumor site. Laser devices and magnetic resonance imagers allow a close examination of cross-sections of the body and brain.
  • The Robert E. Fischell Institute for Biomedical Devices is housed on the fifth floor of A. James Clark Hall, home to state-of-the art core facilities on fabrication and 3D printing, confocal microscopy, small animal imaging, and many other analytical technologies.

Labs

• Bio-Imaging and Machine Vision Laboratory develops technologies for food, biomedical, and biomaterial engineering applications.
• Biochip Collaborative spans five laboratories and research groups in the Clark School of Engineering, the University of Maryland Biotechnology Institute, and the University of Maryland School of Pharmacy. The Collaborative's goal is to enlist molecular bioengineering to "translate" the communication between biological and microfabricated systems in a manner that embraces the fragility of biology.
• Biomolecular and Metabolic Engineering Laboratories employ the tools of "functional" genomics to understand the regulation of genetic circuits during applied stresses. In particular, DNA microarrays are used for analyzing gene expression on a global basis. This, coupled with transcriptional promoter probes, quantitative RT-PCR, Northern and Western analyses ultimately enables close to real time detection of gene expression in targeted circuits.
• Biomolecular Modeling Laboratory aims to explore how molecular behavior dictates macroscopic-scale properties of systems. Professor Matysiak's group utilizes statistical thermodynamics to estimate thermophysical properties from computer simulations on a molecular level. Group members model self-assembly of soft materials such as surfactants, proteins, lipid and polysaccharides.
• Biotherapeutic Development and Delivery Laboratory - The lab aims to uncover new biological insights towards the design and development of novel biotherapeutics (aka biopharmaceuticals), including proteins, extracellular vesicles (exosomes) and others. They also strive to develop new approaches to drug delivery and biomanufacturing using fundamental tools from both engineering and biology.
• Cell and Microenvironmental Engineering Lab - Research in this lab lies at the interface of cell engineering, nano/microtechnology, and quantitative mechanobiology, and integrates principles and techniques from engineering, biology, and physics in order to address questions related to physiological processes and diseases such as cancer and cardiovascular disease.
• Cell Biophysics Laboratory applies the theoretical and experimental machinery of physics and engineering to obtain a quantitative understanding of specific problems inspired by biological systems. The group studies the mechanics and motility of healthy cells, as well as those of cells with pathological conditions.
• Eisenstein Group investigates a variety of questions involving plants, including their remarkable capacity to produce a complex array of interesting compounds, their response to pathogens and disease, and the feasibility of engineering their biosynthetic apparatus for applications ranging from human health to biofuel production.
• Global Biomedical Devices Laboratory - The lab is focused on developing affordable, accessible diagnostic and therapeutic technologies to improve the management of cancers in LMICs. We use engineering design methods, rapid prototyping and fabrication, optical imaging, chemical ablation, bench testing, and animal models to develop biomedical technologies for improving cancer management.
• Human Performance Laboratory - The lab focuses on computer-based communication, monitoring and testing devices aimed at evaluating and understanding the cognitive, motor, and psychomotor skills of workers who use respiratory equipment. The lab's goal is to improve performance and safety for those in potentially hazardous occupations such as emergency rescue, manufacturing, mining, agriculture, and landscaping.
• Immune Engineering Laboratory - The goal of the lab is to develop biomaterials that generate immune responses with specific, tunable characteristics, an idea known as “immunomodulation.” This goal has two complementary thrusts: basic investigations to understand the interactions between synthetic materials and the immune system, and translational studies that exploit these interactions for therapeutic vaccines targeting cancer and autoimmunity.
• Model Analysis Laboratory researches spatial analysis and control of active and passive biological agents in dynamic, intensive and extensive, heterogeneous bioenvironments. Analytical and numerical computational devices are developed within deterministic and stochastic frameworks, coupled with artificial intelligence tools and integrated into multi-dimensional spatial databases to form Decision Support Systems (DSS) aimed at designing strategies for analyzing and controlling the dynamics of nutrients, drugs, toxins and active bioagents from the scale of individual cells through tissues and organs to urban landscapes, watersheds and broad geographical regions.
• Multiscale Biomaterials Engineering Laboratory is dedicated to the research and education on developing multiscale (nano, micro, and macro) biomaterials and devices with bioinspired spatiotemporal complexity to (1) encapsulate and deliver small molecules, genes, peptides/proteins, cells, and tissues and (2) engineer 3D biomimetic systems in vitro, with the ultimate goal of improving the safety and efficacy of cancer treatment, tissue regeneration, and assisted reproduction.
• Nanoscale Interfacial Biology and Engineering Laboratory specializes in the development of new measurements capable of resolving key processes on the nano- to microscale in biology and medicine to aid in the design of more sensitive diagnostics and effective therapeutics. The group integrates nanoparticle-based imaging modalities and advanced 3D human tissue culture models to study the biomolecular and biophysical aspects of fundamental processes that contribute to the onset and progression of disease.
• Optical Therapeutics and Nanotechnology Lab - The lab integrates nanoscience and photobiology to help fight disease and improve our daily lives. We engineer nanometer-scale objects that allow optical and biophysical manipulation of the disease at various levels. This approach could facilitate the study of physiological barriers to drug delivery, immune tolerance, and molecular drug resistance in living animals and in clinical trials. The established photo-responsive nanotechnology could give a broadly enabling platform for a wide variety of applications, ranging from personalized healthcare to military and security.
• Optics Biotech Laboratory studies optics and photonics to devise novel technology for biological research and clinical medicine. In particular, we focus on imaging modalities able to map properties that are difficult or impossible to measure with traditional techniques but with important biomedical applications.
• Photonic Biosensors Laboratory develops integrated microsystems for the diagnosis and study of disease at the cellular and molecular level. Using a combination of microfabrication techniques, the group implements micro total analysis systems for three major research thrusts: infectious disease detection based on DNA signature biosensing; understanding cancer metastasis using a new on-chip assay to identify and enrich highly tumorigenic cells; and low-cost, portable, point-of-sample pesticide, explosives, and toxin detection using 3D optofluidic surface-enhanced Raman spectroscopy scaffolds.
• Tissue Engineering and Biomaterials Laboratory uses the principles of both engineering and life sciences to develop biomaterials that improve the quality of life of ill or injured patients. The lab is used to fabricate polymers into easily implantable biomaterials by first synthesizing novel hydrolytically degradable biomaterials. Molecular and cellular biology principles are then incorporated to understand the interaction of cells, tissues, and higher life systems with these novel biomaterials. Areas of focus in the lab include the study of biomaterials for the delivery of therapeutics, scaffolds for orthopedic tissue engineering applications, and the interaction of biomaterials and tissues.

Fellowships

• Fischell Fellowship in Biomedical Engineering is a unique opportunity for talented and innovative graduate students interested in applied research and product design in the biomedical industry. 
• Fischell Institute and MPower Entrepreneurship Fellowship - This well-established fellowship has helped students transition multiple medical device ideas into prototypes and commercial ventures while earning their Master of Engineering (M.Eng.) degrees. Sponsored project(s) utilize technology developed at the University of Maryland, College Park or University of Maryland, Baltimore. The sponsored project(s) can be a continuation of a senior capstone project. Funding is awarded for one or two year. The fellowship is open to students graduating from engineering, pharmacy, or related STEM programs.
• Graduate School Fellowships - Graduate fellowships are offered through both BIOE and the Graduate School to eligible, meritorious students. Students are encouraged to explore fellowship, scholarship, and internship opportunities from outside UMD.
• More Student Fellowship Opportunities
  • Dean's Fellowships - Offered by graduate programs in order to create greater flexibility in creating overall support packages for students.
  • Flagship Fellowship - Flagship Fellowships are multi-year enhancement awards to be added to fellowship/assistantship offers made by graduate programs and may total $60,000 per student over the duration of the award. 
  • Ronald E. McNair Graduate Fellowship - This program enhances opportunities for campus doctoral programs to recruit and retain outstanding McNair alumni from institutions across the country.
• More Fellowship Opportunities (External) - There are a number of external fellowship opportunities available. Review this list of funding opportunities.
• NSF Graduate Research Fellowship Program (GRFP) was established to help ensure the quality, vitality, and diversity of the scientific and engineering workforce of the United States. A goal of the program is to broaden participation of the full spectrum of diverse talents in STEM. The five-year fellowship provides three years of financial support inclusive of an annual stipend of $37,000.

Scholarships

The Fischell Department of Bioengineering sponsors Scholarships and Awards that recognize students for their excellence in academics, research, and/or service.

• Seymour and Faye Wolf Endowed Scholarship in Bioengineering was established in 2002 to provide an annual scholarship for an undergraduate student studying bioengineering in the A. James Clark School of Engineering.
• Jeffrey C. and Sandra W. Huskamp Endowed Bioengineering Scholarship was established in 2010 to provide scholarships for undergraduate students who are majoring in bioengineering and are in their first, second or third year of study in the A. James Clark School of Engineering.

College and Department Awards

• The Fischell Department of Bioengineering Outstanding Junior Award is presented on the basis of outstanding academic achievement and contributions to the profession and the department by a junior.
• The Fischell Department of Bioengineering Outstanding Senior Award is presented on the basis of outstanding academic achievement and contributions to the profession and the department by a senior.
• The Fischell Department of Bioengineering Outstanding Research Award is presented on the basis of significant contributions to research, the department, and the field of bioengineering.
• The Fischell Department of Bioengineering Outstanding Leadership Award is presented to an excellent student who has shown exemplary leadership within the community, department, university, and profession.
• The Fischell Department of Bioengineering Outstanding Service Award is presented to an excellent student who has contributed significantly to the community, department, university, and profession.
• The A. James Clark School of Engineering Dean's Award - Students nominated for the Dean's Award can be considered for the leadership and service awards.
• The Dinah Berman Memorial Award - Nominees are evaluated based on the following criteria: 1) grade point average, 2) scholastic endeavors, and 3) demonstrated leadership and/or service to the Clark School of Engineering as evidenced by participation in activities that impact students in all engineering majors.
• The A. James Clark School of Engineering Leadership Award - Nominees must meet the following requirements:
  • Undergraduate engineering student
  • Good academic standing
  • Demonstrated outstanding leadership in the Clark School of Engineering as evidenced by participation in activities that impact students in all engineering major
• The Kim Borsavage and Pamela J. Stone Student Award for Outstanding Service - Nominees must have demonstrated outstanding dedication and service to the Clark School of Engineering.
• The A. James Clark School of Engineering International Student Award - Nominees must meet the following requirements:
  • Undergraduate engineering student
  • Good academic standing
  • Demonstrated significant involvement in international engineering activities through leadership or service

Please see the Clark School's scholarship database for a comprehensive list of these opportunities

• ASPIRE offers students a unique opportunity to venture beyond the classroom through collaboration with engineering faculty and staff on mutually interesting projects with industry relevance. ASPIRE introduces undergraduates to the discipline and rewards of industrially-oriented engineering projects. Students perform research during the Fall and/or Spring semesters under the guidance of an engineering faculty or staff mentor. ASPIRE awardees receive a scholarship of $1,000 for each semester project. For Summer projects, students receive a scholarship of $3,000 for the summer. All funds are credited to the awardee's university student account. All continuing projects must submit a new application for each semester or summer.
• Maryland Industrial Partnerships (MIPS) - MIPS provides funding, matched by participating companies, for university-based research projects that help the companies develop new products.
• Medical Device Development Fund (MDDF) is administered by the Maryland Technology Enterprise Institute (Mtech). MDDF provides research funding for medical device prototype development and is open to UMD researchers. The goal of the program is to fund further development of university-owned intellectual property and facilitate technology transfer.
• TEDCO Maryland Innovation Initiative (MII) - MII was created to foster the transition of promising technologies having significant commercial potential from Qualifying Universities, where they were discovered, to the commercial sector, where they can be developed into products and services that meet identified market needs.
• USM Launch Fund - Provides early-stage capital, primarily in the form of non-dilutive grants, ranging from less than $2,000 to $50,000. This capital is designed to bridge foundational gaps, supporting entrepreneurs on their journey to the next steps.

• UM Ventures College Park - Supports and promotes innovative solutions and emerging ventures by providing legal assistance, business expertise, technical know-how, and more.
  • Faculty Startup Program provides a general outline for designing a path to success specific to your needs.
  • Startup Fundamentals Workshops are online sessions where attendees learn about a variety of skills necessary for them to transform their research and technology into impactful solutions that can benefit society. These workshops provide attendees useful information, advice, training, and even access to funding opportunities.  These workshops provide attendees useful information, advice, training, and even access to funding opportunities. Most workshops are hosted virtually via Zoom and many (but not all) are recorded and are available on the StartupUMD YouTube Channel.
  • Startup Process Concierge - The UM Ventures College Park team's goal is to empower UMD faculty and graduate students to transform their research into successful startups by providing resources and customized guidance through rich entrepreneurship ecosystem at the University of Maryland and the State of Maryland.
• UMD Faculty & Graduate Startup Guide - If you have an invention or a great idea for a new venture, then use this interactive guide. Many startup journeys may not be as linear as the steps in this guide, so utilize these resources within the guide from different stages based on what is useful to you.
• UMD I-Corps - I-Corps provides real world training on how to incorporate innovations into commercially viable companies to solve societal problems. The curriculum is based on the Lean Startup framework, through which researchers can better understand the market potential of an innovation.

Accelerators

• Baltimore Life Science Discovery Accelerator (UM-BILD) - With the support of a four-year, $4 million Research Evaluation and Commercialization Hubs (REACH) grant from the National Institutes of Health, the University of Maryland, Baltimore (UMB) and the University of Maryland, Baltimore County (UMBC) will advance the biomedical entrepreneurship and innovation economy in West Baltimore and Greater Baltimore and increase biomedical workforce and startup workforce diversity. The UM-BILD Accelerator is accepting applications through September 3, 2024 for the March 2025 funding cycle (Cohort 2). To be considered for funding, investigators must meet all eligibility requirements and submit a Letter of Intent (LOI) through the REACH Hub application. Apply online.

Challenges

• University of Maryland Medical Center Innovation Challenge is a competition hosted by Dr. Bert O'Malley, UMMC senior leadership, and the University of Maryland, Baltimore (UMB). The Innovation Challenge was launched in March 2021 with the goal of capturing new ideas and concepts, and to harness innovative spirit at the UMMC Downtown and Midtown campuses. Each year, the Innovation Challenge funds up to six inventive projects that advance health outcomes and improve the care experience. The projects have a 12-18 month timeline for completion. 

Incubators

• UM-BILD Incubator - Currently in development, this dedicated “proof-of-concept” hub, with locations in the University of Maryland BioPark and bwtech@UMBC, will grow the life science economy in West Baltimore and Greater Baltimore. This life science incubator will utilize internal core services, specialized equipment, and experts at UMB, UMBC, and other partner institutions.  
• bwtech@UMBC Biotech Incubator features 165,000 sq. ft of office and lab space, including over 40,000 sq. ft of wet lab space, this nationally recognized life science and technology business incubator is equipped to meet the needs of companies of all sizes. It is home to more than 45 companies specializing in life science, clean tech, advanced manufacturing, and engineering, the Biotech Incubator@bwtech helps young businesses start, grow, and stay in Maryland.
• The Grid is a partnership between the University of Maryland Ventures and the University of Maryland Graduate School providing students, entrepreneurs, faculty, and staff a place where innovative health and social impact ideas come to life. The Grid provides entrepreneurial support to students in many ways including partnerships, workshops, mentoring, pitch development, coaching, funding, and career services.

Programs

• Pharmapreneurship® - Exclusive to the University of Maryland School of Pharmacy, pharmapreneurship® describes the School's commitment to supporting and best positioning both faculty and students to achieve their career aspirations and address our nation's health care challenges. Through cutting-edge research initiatives and innovative clinical services, we create an exceptional environment that fosters and values pharmapreneurship among faculty and students.

Centers

• Center for Brain Health and Human Performance brings together leading researchers in neuroscience, genomics, biomechanics, and other fields who are examining innovative techniques and approaches that link UMB’s strengths in TBI and spinal injury with UMD’s strengths in complementary areas in computer science, engineering, physics, and biology.
• Center for Biomedical Engineering and Technology (BioMET) is a collaborative effort between the University of Maryland School of Medicine and the Fischell Department of Bioengineering at the Clark School of Engineering, University of Maryland College Park. BioMET brings together basic biomedical researchers with engineers to develop new strategies and new devices to enhance our ability to treat diseases.
• Center of Excellence in Regulatory Science and Innovation (M-CERSI) is funded by the U.S. Food and Drug Administration. The center focuses on modernizing and improving the ways drugs and medical devices are reviewed and evaluated. Researchers from UMD and UMB work with FDA staff to support the development of new tools, standards and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products.
• Center for Health-Related Informatics and Bioimaging (CHIB) facilitates and accelerate the development of transformative research and technology-driven advances in personalized medicine.
• Center for Innovative Biomedical Resources (CIBR) is the organizational framework for all UMSOM biomedical core resources. CIBR serves as a center of excellence for state-of-the-art technologies, high-tech instrumentation, and expertise that supports biomedical research, clinical practice and health care. Physical consolidation of many core facilities in common space creates a dynamic environment that will enhance and stimulate high impact research through a trans-disciplinary approach. Check out the CIBR Handbook for more information.
• Center for Medical Innovations in Extended Reality (MIXR) - MIXR is building the scientific foundations for designing and assessing extended-reality (XR) applications in medicine. We are exploring XR and machine learning for public health, medical education, clinical care, and therapeutics.
• Maryland Cochlear Implant Center for Excellence (MCICE) combines the research and educational strengths of UMD in audiology and speech-language pathology with the surgical and clinical expertise from School of Medicine faculty at UMB to provide educational training, clinical services, and basic and translational biomedical research on cochlear implants (CIs.)

Institutes

• Institute for Bioscience and Biotechnology Research (IBBR) brings together researchers in academia with corporate and government partners to develop solutions that address major health and scientific challenges, benefit patients, and create economic development in the state.
• Institute for Physical Science and Technology (IPST) pursues interdisciplinary research and education at UMD. The Institute provides support for theoretical and experimental research in areas at the intersection of traditional disciplines such as the UMD-NCI Partnership for Cancer Technology. The partnership serves as a hub for integrative biomedical research and includes students who research is mentored by UMD faculty and investigators from seven other NIH institutes.
• University of Maryland Baltimore Institute for Clinical & Translational Research (UMB ICTR) - The mission of the UMB ICTR is to remove barriers to clinical and translational research by providing high-quality, cost-effective informatics, biostatistics, clinical resources, mentorship, and other core services that will support clinical research, community engagement, ethics and regulatory science, pilot projects, and the development of novel technologies. This Institute is a partnership between UMB and Johns Hopkins University to forge a powerful alliance with the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA). The CTSA program helps support high-quality translational clinical research locally, regionally, and nationally and fosters innovation in research methods, training, and career development.
• University of Maryland Institute for Health Computing (UM-IHC) is a computationally empowered life science research initiative to improve the well-being and health of citizens in Maryland and beyond.

University of Maryland, Baltimore

• BioPark is a biomedical research park on the vibrant academic medical center campus of the University of Maryland, Baltimore (UMB). Its community of life science companies and academic research centers are commercializing new drugs, diagnostics and devices and advancing biomedical research. The 14-acre BioPark on the west side of campus boasts nearly 2 million square feet of lab and office space in 12 buildings plus garage parking and landscaped parks at final build-out. Below are a few of the properties based in the UMB BioPark.
  • 4 MLK - University of Maryland Bio Park in Baltimore: The existing BioPark in Baltimore boasts nearly 2 million square feet of lab and office space. The addition of 4MLK will add an additional 250,000 square feet of space, including wet-lab capable space, flexible lab, office and lab support facilities. The project will also deliver a community gathering/event space and streetscape with retail, food and beverage venues.
  • BioInnovation Center is an ideal environment for companies that require their own dedicated wet lab and/or office space, but may not be ready to build out their own space or commit to a long-term lease. The BioInnovation Center enables companies to expedite their time to market while conserving capital expenditures.
  • Maryland Proton Treatment Center (“MPTC”) is a leading edge cancer center that brings a highly advanced form of cancer treatment - proton therapy - to Baltimore, the State of Maryland, Washington, DC, Delaware and Northern Virginia. This center features five treatment rooms housed in an 110,000 square-foot facility.
• Specialized Facilities - To foster and support UMB’s entrepreneurial faculty, UM Ventures, Baltimore has developed specialized innovation spaces to meet the specific needs of our faculty working to advance their innovations. 
  • Launchpad Medical Device Prototyping Lab is a fully-equipped and staffed technology development lab capable of producing physical and testable medical device prototypes.
  • Launchpad Wet Lab offers UMB faculty entrepreneurs space to perform research and development to advance and de-risk their inventions. The 650 sq. ft. lab is well-appointed for molecular and cell biology discovery development.

University of Maryland, College Park

• A. James Clark Hall boasts more than 100,000 square feet of instructional and research space with three floors dedicated to the Fischell Department of Bioengineering and the Robert E. Fischell Institute for Biomedical Devices. To help spur an organic flow of ideas, Clark Hall houses an Innovation Lab, in which students from all eight engineering departments work collaboratively on cross-disciplinary research and design work. State-of-the-art optical laser and imaging laboratories feature advanced technology in digital fabrication, rapid prototyping, 3-D printing, optics, and bioinformatics. In the imaging suite, students and faculty have the ability to examine molecular resolution of pathogens that show how a nano-carrier delivers a drug to a specific tumor site. Laser devices and magnetic resonance imagers allow a close examination of cross-sections of the body and brain.
  • The Robert E. Fischell Institute for Biomedical Devices is housed on the fifth floor of A. James Clark Hall, home to state-of-the art core facilities on fabrication and 3D printing, confocal microscopy, small animal imaging, and many other analytical technologies.

Universities at Shady Grove

• Biomedical Sciences and Engineering (BSE) Education Facility is a six-level, 220,000 square-foot building and one of the most sustainably-sourced laboratory buildings in the region, earning a LEED Platinum certification by the U.S. Green Building Council. The building houses various academic offices and student services, as well as 20 fully-equipped teaching laboratories, two 120+ seat lecture halls, 12 active learning classrooms, clinical training facilities — including a state-of-the-art dental health facility with 20 dental chairs and four surgical offices, a product design laboratory and maker space for student research and an entrepreneurship lab.

• Baltimore Fund stimulates economic advancement in Baltimore City by supporting Maryland Public Higher Education Institution (PHEI) -created or -sponsored technology companies and affiliated entities locating in the city.
• Maryland Industrial Partnerships (MIPS) - MIPS provides funding, matched by participating companies, for university-based research projects that help the companies develop new products.
• Maryland Momentum Fund is a pre-seed to late-seed stage investment fund that helps promising early-stage companies bridge from grant funding and angel investment to a Series A round of investment. 
• TEDCO Maryland Innovation Initiative (MII) - MII was created to foster the transition of promising technologies having significant commercial potential from Qualifying Universities, where they were discovered, to the commercial sector, where they can be developed into products and services that meet identified market needs.
• UM-BILD Seed Investments - Up to $75,000 and development resources can be provided by UM-BILD to support the translation of basic science research projects into commercial products that will advance patient care. Investigators working on technologies in the therapeutic, medical device, diagnostic, and digital health areas – particularly those that have the potential to address healthcare disparities or otherwise benefit residents of Baltimore – are encouraged to apply for funding. Experience with entrepreneurship is not required; entrepreneurial education and mentorship will be provided as part of the program.
• The UM-BILD Accelerator is accepting applications through September 3, 2024 for the March 2025 funding cycle (Cohort 2).
• USM Launch Fund - Provides early-stage capital, primarily in the form of non-dilutive grants, ranging from less than $2,000 to $50,000. This capital is designed to bridge foundational gaps, supporting entrepreneurs on their journey to the next steps.

• Mtech Ventures is a UMD incubator for technology-based innovations commercialized at the university. This incubator helps early-stage startups survive the critical period in their development between conducting customer discovery and raising their first round of venture capital. The facility offers affordable space and hands-on mentoring for early stage companies.
• UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to support faculty and researchers through the Technology Commercialization Process and to expand industry collaboration.
  • Investor Resources - UM Ventures' primary purpose is to serve the University's faculty, staff, and students and aid in the technology transfer and commercialization processes. We can help you obtain intellectual property protection, increase your research funding through successful partnerships with business and government, and supplement your income with royalty and licensing revenues. Our interdisciplinary team is here to guide your technology through the often confusing technology transfer cycle.

Accelerators

• LaunchPort™ is a medtech manufacturing accelerator located in Baltimore’s Port Covington. This combined manufacturing and Medtech acceleration center allows medical device start-ups and emerging technology developers the ability to co-locate at an experienced, regulated medical device manufacturing center.
• Nucleate Baltimore - This program provides a proven and unparalleled competitive advantage to begin the lab-to-market journey.

Incubators

• LifeBridge Health’s BioIncubator operates as a business incubator to improve human health by bringing together emerging businesses, innovative technologies and leading physicians.

Innovation Hubs

• FastForward R. House innovation hub provides promising ventures affordable space, state-of-the-art equipment and support services in addition to visibility of being part of the Johns Hopkins community.
• Frederick Innovative Technology Center, Inc. (FITCI) is a business incubator and accelerator designed to cultivate entrepreneurship in Frederick, Maryland. FITCI is for scientists and entrepreneurs who want direction to grow their business, we deliver tough love from proven growth fanatics to confidently take you to the next step to exit.
• Johns Hopkins Center for Bioengineering Innovation and Design (CBID) is devoted to two things: education + innovation, both in the service of human health.

Startup Studios

• MDC Studio supports medical device inventors who want to move their ideas beyond the lab into the marketplace. Through design and engineering we translate ideas into working prototypes that can be demonstrated to potential customers and investors. We provide business development, funding support, and regulatory management to build a company around the go-to-market product and the inventor.

Conferences

• BioHealth Capital Region Week from September 17th-19th.
  • This year marks the 10th anniversary of the BioHealth Capital Region Forum, and we are celebrating a decade of advancements that have positioned our region at the forefront of the biopharma industry. The Forum, spanning the first two days (September 17-18), will feature a lineup of speakers who are pioneers and thought leaders in the industry. Attendees will gain invaluable insights through keynote speeches, panel discussions, and sessions that delve into the latest innovations and trends shaping healthcare and biopharmaceuticals.
  • The excitement peaks on September 18th with the 9th Annual Crab Trap Competition. This event showcases emerging companies as they pitch groundbreaking solutions to a panel of esteemed judges for a chance to win significant funding and support. It's not just a competition; it's a launchpad for the next generation of BioHealth innovations, providing startups with the visibility they need to attract investors and partners.
  • The week concludes with the 7th Annual Investment Conference on September 19th, a must-attend for startups seeking investment and investors looking for the next big thing in BioHealth. This conference facilitates direct connections between up-and-coming companies and seasoned investors through curated meetings, fostering a dynamic environment for deal-making and partnership formation.
• Maryland Tech Council Bio Innovation Conference - Connects top life sciences professionals in the region with leading global brands, venture capitalists and promising startups. Created by life sciences professionals for life sciences professionals, this forum offers an exciting and unique opportunity to reach industry leaders and decision makers across the industry and demonstrate to colleagues and clients how your products or services can lead the way to a healthier tomorrow.

Events

• Maryland Tech Council Calendar of Events - MTC hosts a range of events monthly for its members focused on the life sciences, technology, and advocacy for these sectors.

Campuses, Labs, Parks, and More

• 935 Prose at Pike & Rose in North Bethesda promises to offer biotech clients the winning formula for retaining and attracting the world's best talent. The project, located within the nationally acclaimed mixed-use neighborhood of Pike & Rose, will offer 260,000 SF of trophy lab and manufacturing space with expansion opportunities totaling up to 510,000 SF.
• Greencourt Innovation Center (GIC) Flex Lab Program in North Bethesda: Located within the 103,000 SF GIC facility, the GIC Flex Lab Program offers move-in ready wet labs ranging from 200 SF to 15,000 SF, for emerging biotech companies in Montgomery County. GIC provides all of the core lab infrastructures and services to support life science startups as they build and scale their businesses.  
• Johns Hopkins University Belward Campus in Rockville: At over 1.5 million SF and located in the heart of Shady Grove, the Belward Campus will encompass purpose-built lab and R&D facilities across seven buildings. The campus will include a 6-acre public park, athletic fields, fine and casual dining, and more. Expected completion: Q4 2025.
• Milestone Innovation Park in Germantown: Progress Labs at Milestone Innovation Park offers 592,000 square feet of bio manufacturing and support space, with three new state-of-the-art buildings totaling 470,000 square feet being developed and 122,000 square feet of existing space.
• Pinkney Innovation Complex (PIC) for Science and Technology at Montgomery College (MC) in Germantown provides an integrated academic, business, and research environment. Through the PIC Foundation, MC provides space for economic development. Entrepreneurs are provided a resource-rich location.
• Riverside Research Park in Frederick: Nestled along the banks of the scenic Monocacy River, Progress Labs at Riverside Research Park is a world-class biomedical research and development campus in Frederick, Maryland, home to the National Cancer Institute and Frederick National Lab for Cancer Research and Charles River Labs. Co-location with the Frederick National Lab and nearby access to Fort Detrick, federal agencies, and top tier educational institutions makes Progress Labs at Riverside Research Park the premier biotech destination in the region. 
• Shady Grove Innovation District (SGID) in Rockville: The SGID will be a world-class, amenity-rich, mixed-use district catering to the dynamic life science industry at the center of the Shady Grove cluster. At full build-out, the district will feature over 1 million SF of new lab development.
• The Labs at Jefferson Technology Park in Frederick: Intentionally designed for mission-critical lab, office or bio manufacturing use, Jefferson Technology Park will offer a 500,000 SF development integrating research and biomanufacturing facilities in one dynamic campus setting. A shared amenity hub will offer four sides of bright natural light and an elevated mix of amenities, including a cafe, fitness center, and shared coworking spaces.
• University of Maryland Bio Park in Baltimore: The existing BioPark in Baltimore boasts nearly 2 million square feet of lab and office space. The addition of 4MLK will add an additional 250,000 square feet of space, including wet-lab capable space, flexible lab, office and lab support facilities. The project will also deliver a community gathering/event space and streetscape with retail, food and beverage venues.

Competitions

• Crab Trap Competition - Annual event that brings together entrepreneurs with innovative diagnostics, medical devices, therapeutics or other transformative health solutions to compete for a prize package including cash and other in-kind support.

Funding Opportunities

• TEDCO
  • Maryland Innovation Initiative - MII was created to foster the transition of promising technologies having significant commercial potential from Qualifying Universities, where they were discovered, to the commercial sector, where they can be developed into products and services that meet identified market needs. Specifically, it is the intent of the program to foster the commercialization of such technologies through technology validation, market assessment, and the creation of start-up companies in Maryland based on a technology from a Qualified University (a University Start-up), and to accomplish this through collaborations between various schools, departments, and institutions within and among the Qualifying Universities and among other research organizations in the State.
  • Maryland Stem Cell Research Fund (MSCRF) was established by the governor and the Maryland General Assembly under the Maryland Stem Cell Research Act of 2006. The purpose of the fund is to promote state-funded human stem cell research and medical treatments through grants to public and private entities in the state.

Tax Credits

• Biotechnology Investment Incentive Tax Credit - Provides an investor with an income tax credit equal to 33% of an eligible investment in a qualified business up to $250,000 in tax credits, or 50% of an eligible investment in a qualified business up to $500,000 in tax credits if the business is located in designated areas.

• BioBuzz supports life science professionals in nearly every stage of their career as they learn, grow, lead and innovate. Our talent networks harness the power of community and technology to advance careers, grow jobs, and enable individuals and companies to access greater opportunities so that life science innovation and industry thrive.
• BioHealth Innovation connects market relevant research assets to appropriate funding, management and global markets to facilitate the development of commercially viable biohealth products and companies.
• Frederick National Laboratory's Center for Innovation and Strategic Partnerships houses the Partnership Development Office and the Intellectual Property and Strategic Agreements Office, and fosters purposeful innovation across the  Laboratory with the goal of bringing our expertise, capabilities, and technologies to the external research community.  This team brings the Laboratory's distinct capabilities to the broader research community to help solve urgent problems in biomedical research.
• Maryland Department of Commerce Life Sciences Resources
  • Maryland Life Sciences Email Newsletter - Maryland Department of Commerce creates a monthly newsletter featuring a variety of opportunities for local life sciences businesses. Subscribe to receive the latest newsletter.
  • Maryland Life Sciences Directory to make connections and identify partners in the life sciences industry. This free tool allows you to explore more than 1,800 profiles of organizations active in Maryland’s robust life science markets, including biotechnology, medical technology, pharmaceuticals, digital health, manufacturing, regulatory services, and related subsectors.
• Maryland Entrepreneur Hub - Explore a variety of resources you can access for your career or business, such as funding, technical assistance programs, or spaces to work.
• Maryland Tech Council (MTC) is a collaborative community that is actively engaged in building strong technology and life science industries by supporting the efforts of our individual members. We are the largest technology and life sciences trade association in the state of Maryland and provides value by giving members a forum to learn, share, and connect.  
  • Maryland Health Care Product Development Corporation (MHCPDC) stimulates growth of the biomedical industry in the state through “early stage” investment with promising Maryland biomedical and medical technology companies.
  • Maryland Life Sciences (MDLS) is a collaborative community, actively engaged in building stronger life science companies by supporting the efforts of our individual members who are saving and improving lives through innovation. MDLS is a regional association for the life sciences community. We support our member companies who are driving innovation through advocacy, education, workforce development, cost savings programs and connecting entrepreneurial minds. MDLS represents biotechnology, clinical and research data, therapeutic, genetic, medical device, pharmaceutical and service companies that support Maryland’s thriving industry.

• BioHub Maryland helps residents of all backgrounds pursue rewarding careers in life sciences by offering biopharma manufacturing skills training, career resources, and access to hundreds of job openings in life sciences.
• BioTechnical Institute of Maryland, Inc. (BTI) was founded in 1998 as a non-profit to train and place entry-level biotechnicians in Maryland’s rapidly expanding biotech industry. The BTI Laboratory Associates Program provides tuition-free training in basic laboratory skills to bright, ambitious, unemployed and under-employed residents of the region.

Accelerators

• BARDA Accelerator Network fosters the growth of the global health security innovation ecosystem. The Network accelerates the development and commercialization of next-generation health security solutions.
• Endless Frontier Labs (EFL) accelerates the success of early-stage science and technology based startups through a goals-oriented mentorship program. The Life Sciences track is for startups tackling complex problems in biology, chemistry or related fields with applications in therapeutics, drug discovery, drug design, delivery, diagnostics, and other human or animal health-focused verticals.
• LifeX Accelerator - A free, 3 month immersive program for early stage ventures commercializing a technology in digital health, medical devices, or therapeutics.
• MedTech Accelerator - Working with distinguished physicians, researchers and entrepreneurs, MedTech Accelerator cohort companies optimize their offerings, license intellectual property, engage in idea mentoring, and develop funding strategies. 2025 program will take place in beautiful Phoenix, Arizona beginning Sunday, March 16, 2025 continuing through Thursday, March 27, 2025.
• MedTech Innovator Accelerator – Based on feedback from the pitch events and subsequent diligence, 50+ of the most innovative companies from around the world are selected from the MedTech Innovator Road Tour to the Accelerator, a 4-month virtual program from June – October.
• Nucleate Activator - Nucleate's flagship program begins with a “mutual-matching” team formation phase, followed by workshops and mentor office hours, culminating in a final pitch showcase before world-renowned judges.
• E-Team Program, part of the VentureWell Accelerator, supports student ventures as you embark down the path you’re likely to take as an innovator and entrepreneur. We help you advance your invention through a powerful mix of up to $25,000 in grant funding, entrepreneurship training, mentorship by dedicated staff, national recognition, and networking with peers and industry experts.

Incubators

• JLABS @  Washington, DC is a life science and healthcare incubator that is open to entrepreneurs, innovators and startups focused on innovation across the healthcare spectrum, including pharmaceuticals, medical device and health tech.

Bootcamps

• NIH Entrepreneurship Bootcamp is designed to equip life science investigators and nascent companies with specialized innovation and entrepreneurship training. The course requires no prior experience and uses a life science-focused customer discovery process to assess customer and stakeholder needs, and teaches participants to develop stronger business models, market strategies, and commercialization plans in advance of their initial SBIR/STTR application.

Hackathons

• BioHackathon Europe is an annual event that brings together life scientists from around the world. It is organised by ELIXIR Europe, and offers an intense week of hacking, with over 160 participants working on diverse and exciting projects. The goal is to create code that addresses challenges in bioinformatics research.
• Cultivate Tomorrow Hackathon is Nucleate Cultivate's flagship program and will continue to provide an innovative competition format where students can explore creative solutions to the most pressing problems in cellular agriculture. 
• Health System Innovation Lab (HSIL) Hackathon is a transformative event with a clear mission: to empower innovators to create solutions that enhance healthcare systems globally. This dynamic and collaborative hackathon brings together professionals and experts from diverse fields to address critical healthcare challenges through innovation.

• BIO CEO & Investor Conference - One of the largest investor conferences in the industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology.
• Biotechnology Innovation Organazation (BIO) - As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives, but also offer a broad and unbiased venue to seek investment and BD&L opportunities.
• Medtech Innovator LIVE Webinars are one hour in length and are live-streamed on the YouTube Channel. Subscribe to receive weekly reminder emails! Webinars will also be recorded and available for later viewing.
• VentureWell Biomedical Engineering Innovation, Design, and Entrepreneurship Alliance (BME-IDEA) Meeting - Taking place from October 22nd-23rd at Johns Hopkins University in Baltimore. This event is an invaluable opportunity for biomedical engineering faculty, researchers, and industry leaders to come together, share their experiences, and learn from one another. Whether you are looking to enhance your curriculum, explore new teaching methods, or connect with peers in the field, the BME-IDEA Meeting is the place to be. 

Fellowships

• Stanford Biodesign Innovation Fellowship is a 10-month experience that equips aspiring innovators with a proven, repeatable process to identify important health-related needs, invent novel health technologies to address them (including medical devices, diagnostics, digital health, drug delivery, and biotechnology solutions), and prepare to implement those products into patient care through start-up, corporations, or other channels. In addition, the Innovation Fellows become part of the Stanford Biodesign community, which is a life-long, worldwide network of innovators passionate about improving healthcare.

Scholarships

• TYLENOL® Future Care Scholarship - Each year the makers of TYLENOL® award annual scholarships to well deserving students pursuing careers in healthcare.

• DojoGrants is an initiative run by Nucleate Dojo, designed to financially enable U.S. and Canadian undergrads to pursue life sciences-related research opportunities in U.S.-based labs and institutes. Students choose a research area and lab, and we’ll fund you.
• LifeX Ventures was created with the vision as a capital growth company dedicated to de-risk the time, resources, and investment required for life sciences companies to grow and become successful.
• Small Business Innovation Research (SBIR) program offers competitive awards to support small businesses’ early R&D efforts. The proposals are solicited and funded by many of the same federal agencies that fund academic research. Successful SBIR projects sometimes obtain follow-on federal R&D funding or government production contracts
• Small business Education and Entrepreneurial Development (SEED) supports the NIH innovator community in their efforts to validate the potential health impacts of promising scientific discoveries and advance them into healthcare products that improve patient care and enhance health. Developing products across the biomedical spectrum requires NIH’s collaboration with universities and research institutions, small businesses, trade associations and societies, angel investors, venture capitalists, and strategic partners.

• BioBuzz supports life science professionals in nearly every stage of their career as they learn, grow, lead and innovate. Our talent networks harness the power of community and technology to advance careers, grow jobs, and enable individuals and companies to access greater opportunities so that life science innovation and industry thrive. Our regionally-focused networks create, connect and amplify impact across the life science workforce in growing biohubs (BioHealth Capital Region, Greater Philadelphia, Research Triangle Park).
• Biomedical Advanced Research and Development Authority (BARDA) is part of the U.S. Department of Health and Human Services. It's mission is to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.
• Biomedical Engineering Society (BMES) is the professional home for biomedical engineers where we help you navigate your career path and strive to make the work of biomedical engineering, and those in allied fields, more visible.
• Biotechnology Innovation Organization (BIO) - BIO is committed to speaking up for the millions of families around the world who depend upon our success. We are helping to drive a revolution that aims to cure patients, protect our climate, and nourish humanity.
• MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. 
• Nucleate is a student-led organization that represents the largest global community of bio-innovators.

• HackBio provides interactive training, mentorship and networks in data science and bioinformatics for individuals seeking to advance their careers in biotechnology, academics, research and healthcare.

• Robert E. Fischell graduated from UMD with an M.S. in physics in 1953 and was awarded an honorary doctoral degree from UMD in 1996. Dr. Fischell is a scientist and engineer who has had two pioneering careers: his current one inventing life-saving medical devices, and a former one helping create the modern era of space satellites so critical to communications, entertainment, business and national security. Dr. Fischell, who holds more than 200 patents, is the father of modern medical stents, lifetime pacemaker batteries and implantable insulin pumps. He is a member of the National Academy of Engineering and has received numerous awards and recognitions including induction into the Space Technology Hall of Fame. Fischell serves on the Clark School Board of Visitors, as well as on the University of Maryland, College Park Foundation Board of Trustees. In May 2002, Fischell was inducted into the Clark School Innovation Hall of Fame and received Maryland's 2001 Major F. Riddick, Jr. Entrepreneurship Award. Read More.
• Matthew Dowling, Ph.D. '12 is the Chief Scientific Officer and Director of Medcura. Matt completed his graduate work at the Fischell Department of Bioengineering at the University of Maryland (UMD). At UMD, he was awarded the Fischell Fellowship in Biomedical Engineering for his innovative ideas in drug delivery systems. Matt then co-created gel-e, a novel biomaterial platform, raising several initial grants to develop the technology and to launch Medcura as a corporate entity. Matt was the recipient of the Dean’s Doctoral Research Award from the UMD Clark School of Engineering for his work on chitosan-based self-assembled soft materials for use in wound treatment. He has been the Principal Investigator on $10 million in non-dilutive grant awards to Medcura; these have been used to achieve 5 FDA clearances, 2 Breakthrough Device Designations, 28 issued patents, and 10+ peer-reviewed publications in high-impact journals. Matt’s work has been featured on several US and international media outlets including the BBC TV program, Brave New World with Stephen Hawking.

• William E. Bentley is the Robert E. Fischell Distinguished Professor of Engineering and was founding Chair of the Fischell Department of Bioengineering. He is currently Inaugural Director of the Robert E. Fischell Institute for Biomedical Devices and director of the Maryland Technology Enterprise Institute (Mtech). He is also appointed to the Department of Chemical and Biomolecular Engineering at the University of Maryland, College Park and the Institute for Bioscience and Biotechnology Research. At Maryland since 1989, Dr. Bentley has focused his research on the development of molecular tools that facilitate the expression of biologically active proteins, having authored over 350 related archival publications. Recent interests are on deciphering and manipulating signal transduction pathways, including those of bacterial communication networks, for altering cell phenotype. To enable discovery, his lab develops new strategies for opening ‘communication’ between devices and biological systems by the creation and facile assembly of biologically functional interfaces. These concepts are emerging within the fields of ‘biofabrication’ that exploits biological components and processes for assembly and 'bioelectronics" that interface electronics with biology. He has served on advisory committees for the NIH, NSF, DOD, DOE, FDA, USDA, and several state agencies. He has mentored more than 40 PhDs and 15 postdocs, many now in leadership roles within industry, federal agencies, and academia. He co-founded a protein manufacturing company, Chesapeake PERL, based on insect larvae as mini bioreactors. Dr. Bentley was recipient of the SIM’s Schering-Plough Young Investigator Award, the Charles Thom Award of the SIMB, the Marvin Johnson Award of the BIOT Division in the ACS, and the AIChE’s FPB Division Award. He is also a Fellow of the ACS, AAAS, and AIMBE and is an elected member of the American Academy of Microbiology.
• Christopher M. Jewell is an MPower Professor and Robert E. Fischell Institute Professor for Translational Medicine in the Fischell Institute for Biomedical Devices, and a Research Biologist with the United States Department of Veterans Affairs. He is an elected Fellow of the Biomedical Engineering Society (BMES), the Controlled Release Society (CRS), the American Institute for Medical and Biological Engineering (AIMBE), and the Alliance for Cancer Gene Therapy (ACGT). Dr. Jewell was previously appointed as the Minta Martin Professor in the Fischell Department of Bioengineering and the Miegunyah Distinguished Fellow at the Peter Doherty Institute for Infection & Immunity at the University of Melbourne (Australia). He has also served as the Associate Chair for Research and the Director of the BioWorkshop Core Instrumentation Facility at the University of Maryland.  In August 2012, Chris established his lab at the University of Maryland. His research focuses on understanding the interactions between synthetic materials and lymph nodes, and exploiting these interactions for therapeutic vaccination.
• John P. Fisher is an MPower Professor, Distinguished Scholar-Teacher, and Chair of the Fischell Department of Bioengineering. Having served UMD for more than 20 years, he first joined the Department of Chemical Engineering in 2003 and was a founding member of the bioengineering department in 2006. Fisher heads the Tissue Engineering and Biomaterials Lab, where he leads a robust research team in investigating biomaterials, stem cells, bioprinting, and bioreactors for the regeneration of lost tissues. Fisher has served in numerous leadership positions within prominent societies and organizations: Currently, he is a member of the Biomedical Engineering Society Board of Directors; chair of the Council of Chairs, a national assembly of bioengineering and biomedical engineering department chairs; and co-editor-in-chief of Tissue Engineering. He is also the former president of the Americas Chapter of the Tissue Engineering and Regenerative Medicine International Society. Fisher serves on the editorial boards of key biomedical engineering journals such as the Journal of Biomedical Materials Research Part A, Bioprinting, Biofabrication, and the Journal of Tissue Engineering & Regenerative Medicine.